Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Preclinical progress in DOS-47 development program

June 30, 2004

First of two phase I studies for SNS-595

June 30, 2004

Peregrine and Affitech achieve first milestone in collaboration

June 30, 2004

MediGene closes license agreement with U. Chicago for HSV technology

June 30, 2004

GVAX vaccines development update

June 30, 2004

Biocon Biopharmaceuticals expands product portfolio

June 30, 2004

Cyclacel claims new CDK inhibitors for cancer and viral infections

June 29, 2004

Positive interim results from phase I study of Davanat-1

June 29, 2004

Change of indications for phase II trials of KOS-862

June 29, 2004

XL-119 enters phase III trial in bile duct cancer

June 29, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...